Join
Live feed
·
INSIDERFilingvia Quantisnow
Lyell Immunopharma Inc. logo

Chief Operating Officer Hill Stephen J. was granted 4,000 shares and sold $2,520 worth of shares (109 units at $23.12), increasing direct ownership by 26% to 19,031 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LYEL (Lyell Immunopharma Inc.) and more on Quantisnow.